I am a doctor

Peer-reviewed clinical evidence from Pakistan evaluating the use of semaglutide in type 2 diabetes demonstrates improvements in glycemic control, body weight reduction, and overall metabolic outcomes in real-world clinical practice. The study also provides insights into its safety profile and therapeutic effectiveness in routine healthcare settings.